Viewing Study NCT06794268


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2025-12-25 @ 3:13 PM
Study NCT ID: NCT06794268
Status: RECRUITING
Last Update Posted: 2025-02-24
First Post: 2025-01-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module